4//SEC Filing
Pfeffer Cary 4
Accession 0001104659-18-043855
CIK 0001694187other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:29 PM ET
Size
12.8 KB
Accession
0001104659-18-043855
Insider Transaction Report
Form 4
Pfeffer Cary
Director
Transactions
- Conversion
Common Stock
2018-06-29+0→ 0 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2018-06-29−0→ 0 total(indirect: See footnote)→ Common Stock (0 underlying) - Conversion
Common Stock
2018-06-29+0→ 0 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2018-06-29−0→ 0 total(indirect: See footnote)→ Common Stock (0 underlying)
Footnotes (6)
- [F1]Third Rock Ventures III, L.P. ("TRV III") received 8,999,999 shares of Common Stock of the Issuer upon conversion of 45,000,000 shares of Series A Preferred Stock in connection with the closing of the Issuer's initial public offering.
- [F2]TRV III received 341,637 shares of Common Stock of the Issuer upon conversion of 1,708,185 shares of Series B Preferred Stock in connection with the closing of the Issuer's initial public offering.
- [F3]All series of Preferred Stock automatically converted into the Issuer's Common Stock on a 5-for-1 basis upon the closing of the Issuer's initial public offering on June 29, 2018 and had no expiration date.
- [F4]After the above transaction, TRV III owned 9,399,999 shares of Common Stock of the Issuer.
- [F5]These shares are directly held by TRV III. The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F6]After the above transaction, TRV III owned 9,741,636 shares of Common Stock of the Issuer.
Documents
Issuer
Neon Therapeutics, Inc.
CIK 0001694187
Entity typeother
Related Parties
1- filerCIK 0001591092
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:29 PM ET
- Size
- 12.8 KB